AlphAIalphai — Financial news for AI agents
GlobeNewswireNOV 212 min read$NOTV

Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025

WEST LAFAYETTE, Ind., Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Inotiv, Inc. ( NASDAQ: NOTV ) ( the "Company", or "Inotiv" ) , a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and related products and ...

Original reporting
GlobeNewswire · Inc., Inotiv
Published Nov 21, 2025, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Nov 22, 2025, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Inotiv, Inc. to Report Fiscal 2025 Fourth Quarter and Full Year Financial Results and Host Conference Call on Wednesday, December 3, 2025 — source image
Source · www.globenewswire.com
Decision brief

The 30-second read

$NOTVNeutralMed
01

Why it matters

The upcoming earnings release is likely to be a catalyst for short-term trading activity, with potential volatility depending on the results.

02

Market read

While the company's earnings are important to its investors, the overall market impact is limited unless results are significantly unexpected.

03

What to watch

Market reactions may be influenced by broader economic conditions or sector-specific news unrelated to the earnings.

Timing: High, as the event is scheduled for December 3, 2025.

Background

Inotiv, Inc. is a contract research organization specializing in drug discovery and development services. Earnings reports are key events that can influence stock performance.

Company-level read

Ticker impact

$NOTVNeutralMedium confidence
Context

The upcoming financial results and conference call may influence investor sentiment and trading activity.

Expected impact

Potential for increased volatility; possible short-term price movement in either direction depending on earnings outcome.

Evidence & confidence

Earnings reports typically influence stock prices; however, without current financial data or analyst expectations, the exact impact remains uncertain.

Market effects

Sector

The results may influence sentiment in the biotech and pharmaceutical research sectors.

Regional

Limited regional impact; primarily affects US-based investors and markets.

Global

Minimal global market impact unless results significantly deviate from expectations or signal broader industry trends.

Counterpoint

What could challenge this read

The earnings report may be in line or better than expectations, leading to a bullish rally. Alternatively, poor results could cause a sharp decline.

Key entities

  • Company
    Inotiv, Inc.

    A leading contract research organization in the pharmaceutical industry.

Read at source← All news

Related articles

AUG 11
$PMed

Everpure Lands New Design Win with Second Top-Five Hyperscaler

Everpure (NYSE: P) said it secured a design win and supply agreement with a second top-five hyperscaler, building on a similar win announced in late 2024. The company attributes the deal to its DirectFlash technology for hyperscale storage. Everpure expects revenue contributions starting in fiscal 2028 and beyond.

itwire.com2 min
AUG 11
$LNTMedAI 8/10

ONGC awards offshore contracts to L&T Energy Hydrocarbon Offshore

Larsen & Toubro’s subsidiary L&T Energy Hydrocarbon Offshore (LTEH Offshore) won offshore contracts from Oil & Natural Gas Corporation (ONGC) for India’s western coast. The awards cover ONGC’s Pipeline Replacement Project (PRP-X) and construction of four wellhead platforms. L&T said combined contract value is INR 50-100 billion (about $525.2m-$1.05b).

bgnes.com3 min
AUG 11
$LMTMedAI 8/10

Lockheed Martin Awarded Combat Systems Contract for Australian Submarines

According to Australia’s Submarine Agency, it awarded Lockheed Martin a two-year AUD 26.5 million (USD 18.7 million) contract to develop a sovereign Combat Systems Integration capability for Australia’s future Virginia-class submarines under AUKUS. The work includes U.S.-based subject-matter support and a market analysis of Australia’s supply-chain needs for local suppliers.

marinelink.com2 min
AUG 11
$BKRMed

Baker Hughes to Supply Subsea Systems for Kutei Northern Hub

Baker Hughes said it won a contract to supply subsea production systems and digital solutions for the Kutei Northern Hub offshore Indonesia. The deal with Searah North Ganal, a subsidiary of Searah Limited (JV of Eni and Petronas), covers 17 deepwater horizontal tree systems plus manifolds, control and distribution equipment, and Cordant asset protection and condition monitoring.

oedigital.com2 min
AUG 11
$DISMed

Disney, Comcast reach deal, lifting NFL Network blackout

Comcast and Disney reached an agreement to end the NFL Network blackout for Comcast Xfinity TV subscribers, resuming NFL Network and NFL RedZone in time for the 2026 season. The blackout began after their contract expired in late April. Disney owns 72% of ESPN, which took over NFL Media assets earlier this year. Terms were not disclosed.

740thefan.com3 min
AUG 11
$ABUSMed

Could Arbutus Biopharma Corporation (ABUS) Turn its Moderna, Inc. (MRNA) Settlement Into a Lasting Biotech Advantage?

Arbutus Biopharma (ABUS) received about $178 million from Moderna (MRNA) as its share of a $950 million noncontingent LNP patent settlement, with reimbursement of legal costs and an expected Q3 dividend tied to Genevant. ABUS reported Q1 2026 revenue of $179.1 million and net income of $169.7 million. Moderna reported Q2 2026 revenue of $145 million and a net loss of $782 million, plus FDA approval for mFLUSIVA.

insidermonkey.com6 min